Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.

Lemos MM, Watanabe R, Carvalho AB, Jancikic AD, Sanches FM, Christofalo DM, Draibe SA, Canziani ME.

Clin Nephrol. 2013 Jul;80(1):1-8. doi: 10.5414/CN107630.

PMID:
23442255
2.

A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators.

Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18.

PMID:
18423809
3.

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.

Takei T, Otsubo S, Uchida K, Matsugami K, Mimuro T, Kabaya T, Akiba T, Nitta K.

Nephron Clin Pract. 2008;108(4):c278-83. doi: 10.1159/000127361. Epub 2008 Apr 22.

PMID:
18434749
4.

Effect of Statins on the Progression of Coronary Calcification in Kidney Transplant Recipients.

Yazbek DC, de Carvalho AB, Barros CS, Medina Pestana JO, Canziani ME.

PLoS One. 2016 Apr 21;11(4):e0151797. doi: 10.1371/journal.pone.0151797. eCollection 2016.

5.

Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.

Kakuta T, Tanaka R, Hyodo T, Suzuki H, Kanai G, Nagaoka M, Takahashi H, Hirawa N, Oogushi Y, Miyata T, Kobayashi H, Fukagawa M, Saito A.

Am J Kidney Dis. 2011 Mar;57(3):422-31. doi: 10.1053/j.ajkd.2010.10.055. Epub 2011 Jan 15. Erratum in: Am J Kidney Dis. 2011 May;57(5):804.

PMID:
21239096
6.

Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y.

J Am Coll Cardiol. 2014 Jan 7-14;63(1):62-70. doi: 10.1016/j.jacc.2013.09.017. Epub 2013 Sep 26.

7.
8.

Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.

Hong YJ, Jeong MH, Hachinohe D, Ahmed K, Choi YH, Cho SH, Hwang SH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Circ J. 2011;75(2):398-406. Epub 2010 Dec 9.

9.

The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.

Budoff MJ, Kessler P, Gao YL, Qunibi W, Moustafa M, Mao SS.

Acad Radiol. 2008 Jan;15(1):58-61.

PMID:
18078907
10.

Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease.

Sawara Y, Takei T, Uchida K, Ogawa T, Yoshida T, Tsuchiya K, Nitta K.

Intern Med. 2008;47(17):1505-10. Epub 2008 Sep 1.

11.
12.

Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.

Shin ES, Garcia-Garcia HM, Okamura T, Serruys PW.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1643-52. doi: 10.1007/s10554-011-9989-9. Epub 2011 Dec 18.

PMID:
22179944
13.
14.

Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.

Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2010 Nov 1;106(9):1241-7. doi: 10.1016/j.amjcard.2010.06.046. Epub 2010 Sep 9.

PMID:
21029819
15.

Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease.

Abe M, Maruyama N, Yoshida Y, Ito M, Okada K, Soma M.

Endocr J. 2011;58(8):663-74. Epub 2011 Jun 14.

16.

Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).

Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M; COSMOS Investigators.

Circ J. 2009 Nov;73(11):2110-7. Epub 2009 Oct 5.

17.

Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.

Abe M, Maruyama N, Okada K, Matsumoto S, Matsumoto K, Soma M.

J Atheroscler Thromb. 2011;18(11):1018-28. Epub 2011 Sep 15.

18.

Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe.

Yamazaki D, Ishida M, Watanabe H, Nobori K, Oguma Y, Terata Y, Koyama T, Iino K, Kosaka T, Ito H.

Lipids Health Dis. 2013 Feb 4;12:9. doi: 10.1186/1476-511X-12-9.

19.

Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.

Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ.

N Engl J Med. 1998 Dec 31;339(27):1972-8.

20.

Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.

Tam LS, Li EK, Shang Q, Tomlinson B, Lee VW, Lee KK, Li M, Kuan WP, Li TK, Tseung L, Yip GW, Freedman B, Yu CM.

Scand J Rheumatol. 2011 Nov;40(6):411-21. doi: 10.3109/03009742.2011.586649. Epub 2011 Aug 26.

PMID:
21867445
Items per page

Supplemental Content

Write to the Help Desk